Tung NM, Robson ME, Li T, Nanda R, et al. TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2. J Clin Oncol 2026 Jan 28:JCO2502075. doi: 10.1200/JCO-25-02075.
PMID: 41604601